Updating results

212 results for urinary tract infections Sort: Relevance | Date

Urinary tract infections

Everything NICE has said on diagnosing, treating and managing urinary tract infections including lower (cystitis), upper (acute pyelonephritis) and recurrent UTIs in people with or without a catheter in an interactive flowchart

NICE Pathway Published August 2012 Last updated February 2019

Urinary tract infection in under 16s: diagnosis and management (CG54)

This guideline covers diagnosing and managing first or recurrent upper or lower urinary tract infections in infants, children and young people. It aims to achieve more consistent clinical practice, based on accurate diagnosis and effective management.

Clinical guideline Published August 2007 Last updated October 2018

ESNM74: Complicated urinary tract infections: ceftolozane/tazobactam

Summary of the evidence on ceftolozane/tazobactam for treating complicated urinary tract infections to inform local NHS planning and decision-making

Evidence summary Published June 2016

Urinary tract infection (recurrent): antimicrobial prescribing (NG112)

This guideline sets out an antimicrobial prescribing strategy for preventing recurrent urinary tract infections in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published October 2018

Urinary tract infection

All NICE products on Urinary tract infection. Includes any guidance, advice, NICE Pathways and quality...

Urinary tract infection (catheter-associated): antimicrobial prescribing (NG113)

This guideline sets out an antimicrobial prescribing strategy for catheter-associated urinary tract infection in children, young people and adults. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published November 2018

Urinary tract infection (lower): antimicrobial prescribing (NG109)

This guideline sets out an antimicrobial prescribing strategy for lower urinary tract infection (also called cystitis) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published October 2018

Urinary tract infection in children and young people (QS36)

This quality standard covers diagnosing and managing urinary tract infection in infants, children and young people (under 16). It includes new and recurrent infections of the upper or lower urinary tract. It describes high-quality care in priority areas for improvement.

Quality standard Published July 2013 Last updated September 2017

Urinary incontinence in neurological disease: assessment and management (CG148)

This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease. It aims to improve care by recommending specific treatments based on what symptoms and neurological conditions people have.

Clinical guideline Published August 2012

Urinary incontinence in neurological disease

Everything NICE has said on managing lower urinary tract dysfunction resulting from neurological disease and injury in an interactive flowchart

NICE Pathway Published August 2012 Last updated October 2018

Pyelonephritis (acute): antimicrobial prescribing (NG111)

This guideline sets out an antimicrobial prescribing strategy for acute pyelonephritis (upper urinary tract infection) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published October 2018

Urinary incontinence in women

Everything NICE has said about managing urinary incontinence in women in an interactive flowchart

NICE Pathway Published September 2013 Last updated January 2019

Healthcare-associated infections: prevention and control in primary and community care (CG139)

This guideline covers preventing and controlling healthcare-associated infections in children, young people and adults in primary and community care settings. It provides a blueprint for the infection prevention and control precautions that should be applied by everyone involved in delivering NHS care and treatment.

Clinical guideline Published March 2012 Last updated February 2017

ES16: Antimicrobial prescribing: Ceftazidime/avibactam

Summary of the evidence on ceftazidime/avibactam for complicated intra-abdominal and UTI infections and hospital-acquired pneumonia

Evidence summary: antimicrobial prescribing Published November 2017

Prostatitis (acute): antimicrobial prescribing (NG110)

This guideline sets out an antimicrobial prescribing strategy for acute prostatitis. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published October 2018

Infection prevention and control (QS61)

This quality standard covers preventing and controlling infection in adults, young people and children receiving healthcare in primary, community and secondary care settings. It includes preventing healthcare-associated infections that develop because of treatment or from being in a healthcare setting. It describes high-quality care in priority areas for improvement.

Quality standard Published April 2014

Lower urinary tract symptoms in men: management (CG97)

This guideline covers managing lower urinary tract symptoms (LUTS) in men over 18. It aims to improve the quality of life for men with LUTS by recommending which assessments they should receive, and when conservative management, drug treatment and surgery can help.

Clinical guideline Published May 2010 Last updated June 2015

Peristeen transanal irrigation system for managing bowel dysfunction (MTG36)

Evidence-based recommendations on the Peristeen transanal irrigation system for people with bowel dysfunction

Medical technologies guidance Published February 2018

Prostatitis – antimicrobial prescribing

Everything NICE has said on antimicrobial prescribing for acute prostatitis in an interactive flowchart.

NICE Pathway Published October 2018

Fever in under 5s (QS64)

This quality standard covers the assessment and early management of fever with no obvious cause in babies and children (from birth to 5 years). It describes high-quality care in priority areas for improvement.

Quality standard Published July 2014

MIB121: Farco-fill Protect for indwelling urinary catheterisation

Advice on the use of Farco-fill Protect for inflating Foley catheter balloons for indwelling (in-situ) urinary catheterisation to aid local decision-making

Medtech innovation briefing Published September 2017

Self-limiting respiratory tract and ear infections – antibiotic prescribing

Everything NICE has said on antibiotic prescribing for self-limiting respiratory tract and ear infections in primary care in an interactive flowchart

NICE Pathway Published August 2012 Last updated February 2019

Shared learning award winners and finalists

conference. 2018 award winner: Reducing incidence of Urinary Tract Infections by promoting hydration in care homes A multi-disciplinary

Published February 2019

Antimicrobial stewardship

Everything NICE has said on effective antimicrobial medicine use and preventing the spread of resistant microbes in an interactive flowchart

NICE Pathway Published August 2015 Last updated August 2018

Prevention and control of healthcare-associated infections

Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart

NICE Pathway Published March 2012 Last updated November 2018

Reducing incidence of Urinary Tract Infections by promoting hydration in care homes

Shared learning Published April 2018 Last updated June 2018

Surgical site infections: prevention and treatment (CG74)

This guideline covers preventing and treating surgical site infections in adults, young people and children who are having a surgical procedure involving a cut through the skin. It recommends effective methods to use before, during and after surgery to minimise the risk of infection.

Clinical guideline Published October 2008 Last updated February 2017

ESNM75: Complicated intra-abdominal infections: ceftolozane/tazobactam

Summary of the evidence on ceftolozane/tazobactam for treating complicated intra-abdominal infections to inform local NHS planning and decision-making

Evidence summary Published June 2016

Endorsement

NICE Endorsement

Published March 2019

Dyspepsia and gastro-oesophageal reflux disease

Everything NICE has said on investigating and managing dyspepsia and gastro-oesophageal reflux disease in an interactive flowchart

NICE Pathway Published September 2014 Last updated October 2018

Dapagliflozin in combination therapy for treating type 2 diabetes (TA288)

Evidence-based recommendations on dapagliflozin (Forxiga) in combination therapy for treating type 2 diabetes in adults

Technology appraisal guidance Published June 2013 Last updated November 2016

Holmium laser prostatectomy (IPG17)

Evidence-based recommendations on holmium laser prostatectomy (removal of the prostate) for treating Benign prostatic obstruction (BPO)

Interventional procedures guidance Published November 2003

Fever in under 5s: assessment and initial management (CG160)

This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5. It aims to improve clinical assessment and help healthcare professionals diagnose serious illness among young children who present with fever in primary and secondary care.

Clinical guideline Published May 2013 Last updated August 2017

Electrocautery cutting balloon treatment for pelviureteric junction obstruction (IPG324)

Evidence-based recommendations on electrocautery cutting balloon treatment for pelviureteric junction (PUJ) obstruction

Interventional procedures guidance Published December 2009

Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse (IPG584)

Evidence-based recommendations on uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse in women

Interventional procedures guidance Published June 2017

MIB123: Memokath-028, 044 and 045 stents for urethral obstruction

Advice on the use of Memokath-028, 044 and 045 stents for urethral obstruction and bladder neck or outlet obstructions in men to aid local decision-making

Medtech innovation briefing Published October 2017

Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia (IPG475)

Evidence-based recommendations on prostatic urethral lift implants to treat lower tract symptoms secondary to benign prostate hyperplasia (enlarged prostate)

Interventional procedures guidance Published January 2014

Endopyelotomy for pelviureteric junction obstruction (IPG325)

Evidence-based recommendations on endopyelotomy for treating pelviureteric junction (PUJ) obstruction

Interventional procedures guidance Published December 2009

Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (TA390)

Evidence-based recommendations on canagliflozin (Invokana), dapagliflozin (Forxiga) and empagliflozin (Jardiance) for treating type 2 diabetes in adults

Technology appraisal guidance Published May 2016

Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids (IPG30)

Evidence-based recommendations on magnetic resonance (MR) image-guided percutaneous laser ablation for treating uterine fibroids (leiomyomas/myomas)

Interventional procedures guidance Published December 2003

Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention (IPG536)

Evidence-based recommendations on sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention

Interventional procedures guidance Published November 2015

Mirabegron for treating symptoms of overactive bladder (TA290)

Evidence-based recommendations on mirabegron (Betmiga) for treating the symptoms of overactive bladder

Technology appraisal guidance Published June 2013

NICE impact: antimicrobial resistance

How NICE recommendations are being used to slow the emergence of antimicrobial resistance

Published November 2018